TR200201141T2 - 2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı - Google Patents

2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı

Info

Publication number
TR200201141T2
TR200201141T2 TR2002/01141T TR200201141T TR200201141T2 TR 200201141 T2 TR200201141 T2 TR 200201141T2 TR 2002/01141 T TR2002/01141 T TR 2002/01141T TR 200201141 T TR200201141 T TR 200201141T TR 200201141 T2 TR200201141 T2 TR 200201141T2
Authority
TR
Turkey
Prior art keywords
dihydro
drug
amino
production
quinazolines
Prior art date
Application number
TR2002/01141T
Other languages
English (en)
Inventor
Weichert Andreas
Albus Udo
Jansen Hans-Willi
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200201141T2 publication Critical patent/TR200201141T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formül I' e göre olan 2-amino-3,4-dihidro-kinazolin' in ve bunlarin farmakolojik tahammül edilebilir tuzlarinin isemik durumlarin tedavi edilmesi ve profilaksina yönelik bir ilacin üretimi için kullanimi tarif edilmektedir. R1, R2 ve R3 istemlerde belirtilen anlamlara sahiptirler. FORMÜL(I)
TR2002/01141T 1999-10-27 2000-10-14 2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı TR200201141T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19951702A DE19951702A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten

Publications (1)

Publication Number Publication Date
TR200201141T2 true TR200201141T2 (tr) 2002-11-21

Family

ID=7927021

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01141T TR200201141T2 (tr) 1999-10-27 2000-10-14 2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı

Country Status (28)

Country Link
US (1) US6331546B1 (tr)
EP (1) EP1244454B1 (tr)
JP (1) JP2003512420A (tr)
KR (1) KR20020041831A (tr)
CN (1) CN1181822C (tr)
AR (1) AR026242A1 (tr)
AT (1) ATE324111T1 (tr)
AU (1) AU7664800A (tr)
BR (1) BR0014985A (tr)
CA (1) CA2388965A1 (tr)
CZ (1) CZ20021414A3 (tr)
DE (2) DE19951702A1 (tr)
EE (1) EE200200215A (tr)
HK (1) HK1050480A1 (tr)
HR (1) HRP20020363A2 (tr)
HU (1) HUP0203774A3 (tr)
IL (1) IL149160A0 (tr)
MX (1) MXPA02004035A (tr)
NO (1) NO20021710L (tr)
NZ (1) NZ518588A (tr)
PL (1) PL356399A1 (tr)
RU (1) RU2002113667A (tr)
SK (1) SK5582002A3 (tr)
TR (1) TR200201141T2 (tr)
TW (1) TWI227135B (tr)
WO (1) WO2001030328A2 (tr)
YU (1) YU30602A (tr)
ZA (1) ZA200204057B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69927987T2 (de) * 1998-08-13 2006-11-09 Hadasit Medical Research Services & Development Co. Ltd. Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
WO2003048129A1 (de) * 2001-12-05 2003-06-12 Aventis Pharma Deutschland Gmbh Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
DE10163914A1 (de) * 2001-12-22 2003-07-03 Aventis Pharma Gmbh Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
DE10312963A1 (de) * 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560601A (en) 1968-11-25 1971-02-02 Ford Motor Co Process for manufacturing porous thermoplastic sheet material
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
WO1994007498A1 (en) * 1992-10-07 1994-04-14 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical composition for inhibiting tumor necrosis factor production
DE19713427A1 (de) * 1997-04-01 1998-10-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
KR20020041831A (ko) 2002-06-03
WO2001030328A3 (de) 2002-06-20
HRP20020363A2 (en) 2004-02-29
WO2001030328A2 (de) 2001-05-03
IL149160A0 (en) 2002-11-10
CA2388965A1 (en) 2001-05-03
CZ20021414A3 (cs) 2002-07-17
EP1244454A2 (de) 2002-10-02
PL356399A1 (en) 2004-06-28
AU7664800A (en) 2001-05-08
EE200200215A (et) 2003-06-16
ZA200204057B (en) 2003-02-26
NZ518588A (en) 2004-06-25
HK1050480A1 (en) 2003-06-27
AR026242A1 (es) 2003-02-05
NO20021710D0 (no) 2002-04-11
SK5582002A3 (en) 2002-08-06
JP2003512420A (ja) 2003-04-02
EP1244454B1 (de) 2006-04-26
RU2002113667A (ru) 2004-01-10
ATE324111T1 (de) 2006-05-15
NO20021710L (no) 2002-04-11
MXPA02004035A (es) 2002-10-11
HUP0203774A2 (en) 2003-05-28
CN1384747A (zh) 2002-12-11
BR0014985A (pt) 2003-07-22
CN1181822C (zh) 2004-12-29
DE50012667D1 (de) 2006-06-01
HUP0203774A3 (en) 2003-07-28
TWI227135B (en) 2005-02-01
DE19951702A1 (de) 2001-05-03
US6331546B1 (en) 2001-12-18
YU30602A (sh) 2004-12-31

Similar Documents

Publication Publication Date Title
TR200201144T2 (tr) NFKB aktivitesinin modülasyonu için ikame edilmiş indoller
TR200000520A2 (tr) 4-Fenil-piridin türevleri.
ES2151156T3 (es) Derivados de acidos n-(aroil)glicina hidroxamicos y compuestos relacionados.
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
ATE445400T1 (de) Hydantion-derivate als hemmer von matrix- metalloproteinasen
TR199802296T2 (tr) Yeni 2,3 disübstitüte-4 (3H)-kinazolinonlar
TR200101938T2 (tr) Pde-ıv inhibe edici aktivitesi olan fenilfenantridinler.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK1204650T3 (da) Substituerede 2-arylbenzazol-forbindelser og anvendelse deraf som antitumormidler
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
TR199802060T2 (tr) Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi.
BG108426A (en) Novel sulfonic acid derivatives
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
ATE368643T1 (de) Faktor xa benzamidin inhibitoren
NZ515304A (en) Bradykinin receptor antagonists
DK1173439T3 (da) Halogenalkoxy-imidazonaphthyridiner
SE9701304D0 (sv) Compounds
NO20013409L (no) Anvendelse av pyrimidin-derivater for forhindring og behandling av cerebral ischemi
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
SE9803773D0 (sv) Compounds
TR199800386T1 (tr) Analjezik ajan olarak kullanilan optik aktiviteye sahip fenil pirimidin türevleri.
TR200201141T2 (tr) 2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı
TR200002893A2 (tr) Kinolin-4-il türevleri II
TR200200614T2 (tr) Vitronektin reseptörü antagonistleri
NO20021502L (no) Kinazolinoner